-
Trump's face could appear on US $250 bill
-
Mistral says would not interfere if its AI is used by defence customers
-
Canada PM backs 'fortress North America' ahead of US trade talks
-
Flooding in north and east Syria as Euphrates level rises
-
Defending champion Gauff reaches French Open third round
-
Musk defends AI ambitions as IPO reveals trouble
-
Five things to know about heatwaves in Europe
-
Israel freezes out UN chief over sexual violence blacklist
-
US, Iran agree deal framework but need Trump sign-off: sources
-
Italy on red alert as France, Portugal beat hottest May day record
-
Oil advances, stocks drift on fresh US-Iran strikes
-
'Terrorist' knife attack wounds 3 at Swiss train station: official
-
'You are not alone' in Ebola fight, vows DR Congo-bound WHO chief
-
Sinner 'hits wall' as French Open bid collapses
-
France's Magnier sprints to Giro 18th stage win, Vingegaard in pink
-
Top EU economies vow to speed up financial integration
-
Israeli strike near Beirut as Lebanon says raids kill 14
-
Mosquitoes can learn to love common repellent, scientists find
-
US revises first quarter growth down while inflation climbs
-
Italy on red alert as Portugal beats record for hottest May day
-
Latvia gets new centre-right govt after row over stray Ukraine drones
-
France's Kouame, 17, youngest man into Slam third round since Nadal
-
Netflix criticises German plan to make streamers invest more locally
-
'Dizzy' Sinner wilts in French Open heat, out in second round
-
Ailing Sinner crashes out of French Open, Sabalenka waits
-
Italy on red alert as heatwave bakes Europe
-
UK risks a 'lost generation' of jobless young people
-
Attacker wounds three at Swiss train station with 'bladed weapon'
-
Neymar a doubt for Brazil's World Cup opener due to injury
-
Norway's Queen leaves hospital amidst mounting fears over princess
-
US, Iran accuse each other of violating truce after attacks
-
France inches towards symbolic repealing of slavery legislation
-
Oil climbs, stocks drop on fresh US-Iran strikes
-
Scotland boss Clarke signs new four-year contract
-
Italian police seize $232 mn in late mafia boss's assets
-
EU fines Temu 200 mn euros over illegal products
-
Fire in Kenya girls' school dorm kills 16
-
French AI firm Mistral announces deals with BMW, Airbus
-
US, Iran trade strikes in most serious clash since truce began
-
'Immense' leverage: why AI chip workers are demanding more
-
Online horror phenomenon turns movie blockbuster with 'Backrooms'
-
Latvia to get new govt after row over stray drones
-
Oil rises and Asia stocks slide after new US strikes on Iran
-
France moves towards symbolic repealing of slavery legislation
-
'Six machine' Sooryavanshi, 15, stakes India claim with new stunning knock
-
China's military says drove away Dutch warship in South China Sea
-
Israel strikes Tyre after declaring 'combat zones' in south Lebanon
-
US strikes Iran, drawing retaliatory attack on American base
-
Temperatures likely to remain at record levels in 2026-2030: UN
-
New Zealand boosts defence spending in face of 'adverse' security environment
Disgraced surgeon on trial in Sweden over windpipe transplants
An Italian doctor who made headlines for pioneering windpipe surgery went on trial in Sweden on Wednesday, charged with assault for performing the experimental procedure.
Paolo Macchiarini won praise in 2011 after claiming to have performed the world's first synthetic trachea transplants using stem cells while he was a surgeon at Stockholm's Karolinska Institute.
The procedure was hailed as a breakthrough in regenerative medicine.
But allegations soon emerged that the risky procedure had been carried out on at least one person who had not been critically ill at the time of the operation.
The 63-year-old appeared in court in a blue suit Wednesday, where he listened to translated audio as prosecutors listed the charges of "aggravated assault" against three patients.
- 'Disregard for science' -
The Karolinska Institute has confirmed that the three individuals have since died, but did not directly link the deaths to the operations.
"Macchiarini has carried out the surgery with complete disregard for science and tried experience," prosecutor Karin Lundstrom-Kron told the court.
As prosecutors presented their case they referenced both external and internal reviews of the case, including one published in 2016 by physician Kjell Asplund, who argued that Macchiarini should never have been employed by Karolinska in the first place.
"It is clear that this method has not worked," prosecutor Jim Westerberg said, adding that Macchiarini had embellished the benefits of the procedure.
Macchiarini, who took notes without showing much emotion, has maintained the operations constituted treatments and not experiments, and denied being criminally responsible.
"He contends that he has performed health care, cured and helped," Macchiarini's lawyer Bjorn Hurtig told AFP during a recess.
The prosecution's presentation of evidence is expected to continue over several days so the defence will likely not be able to present its side until next week.
But Hurtig said they had "high hopes" they would be able to counter the prosecution's evidence.
"There are quite a lot of gaps in that evidence and there is a lot of evidence that we argue are favourable to our view of things," he said.
- Downplayed risks -
In 2013, the Karolinska hospital suspended all transplants and refused to extend Macchiarini's contract as a surgeon.
A year later, several surgeons at the hospital filed a complaint alleging that Macchiarini had downplayed the risks of the procedure.
Macchiarini carried out three surgeries at Karolinska University Hospital in 2011 and 2012, using an artificial windpipe made of plastic and coating it with the patient's own stem cells.
Together with his colleagues, he performed a total of eight such transplants between 2011 and 2014, the five others taking place in Russia.
An external review in 2015 found Macchiarini guilty of research misconduct, but despite sacking him, the Karolinska Institute repeatedly defended him until 2018, when it found him and several other researchers guilty.
The university's principal stepped down over the scandal, as well as a number of other people.
Medical journal The Lancet in 2018 retracted two papers authored by Macchiarini.
The trial, held in the Solna district court near the Karolinska Institute, is scheduled to take place over 13 days.
S.Abdullah--SF-PST